


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:48:51Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405304" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405304</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Mater Sci Mater Med</journal-id><journal-id journal-id-type="iso-abbrev">J Mater Sci Mater Med</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Journal of Materials Science. Materials in Medicine</journal-title></journal-title-group><issn pub-type="ppub">0957-4530</issn><issn pub-type="epub">1573-4838</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405304</article-id><article-id pub-id-type="pmcid-ver">PMC12405304.1</article-id><article-id pub-id-type="pmcaid">12405304</article-id><article-id pub-id-type="pmcaiid">12405304</article-id><article-id pub-id-type="pmid">40892352</article-id><article-id pub-id-type="doi">10.1007/s10856-025-06912-4</article-id><article-id pub-id-type="publisher-id">6912</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Biocompatibility Studies</subject></subj-group></article-categories><title-group><article-title>In vitro experimental study of MC-PMMA containing vancomycin for the prevention of infection in open bone defects</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="H">Haitao</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bo</surname><given-names initials="Y">Yu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gao</surname><given-names initials="P">Pengcheng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Z">Zhizhong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Qiu</surname><given-names initials="S">Shaodong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Feng</surname><given-names initials="G">Gangning</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="Z">Zongqiang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="H">He</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Mi</surname><given-names initials="Z">Zhanhu</given-names></name><address><email>mzh13519209728@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02h8a1848</institution-id><institution-id institution-id-type="GRID">grid.412194.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1761 9803</institution-id><institution>Department of Traumatic Orthopedics, </institution><institution>General Hospital of Ningxia Medical University, </institution></institution-wrap>Yinchaun, Ningxia China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02h8a1848</institution-id><institution-id institution-id-type="GRID">grid.412194.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1761 9803</institution-id><institution>Ningxia Medical University, </institution></institution-wrap>Yinchaun, Ningxia China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>36</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">496088</issue-id><elocation-id>71</elocation-id><history><date date-type="received"><day>10</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>5</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="10856_2025_Article_6912.pdf"/><abstract id="Abs1"><p id="Par1">In this study, vancomycin, bone cement (PMMA) and mineralized collagen (MC) were mixed in order to obtain a new composite drug-carrying biomaterial, which has good results in both drug slow release, good biocompatibility, and good growth of osteoblasts, osteoclasts, and mesenchymal stem cells on the surface of the biomaterial, which provides a new therapeutic idea for the clinical treatment of bone defect infections. In this study, the drug retardation system of vancomycin and mineralized collagen composite bone cement-carrying biomaterials was prepared in proportion to the drug retardation system, and the experimental studies were carried out using electron microscope scanning, HPLC drug retardation analysis, in vitro antimicrobials, and co-cultivation of osteoclasts, osteoblasts, and mesenchymal stem cells. We found that the composite drug-carrying material of vancomycin, bone cement and mineralized collagen had good slow-release effect and antimicrobial properties, and the addition of vancomycin and bone cement to mineralized collagen material had even better drug-release efficiency than that of bone cement plus vancomycin alone. In vitro antimicrobial showed that the composite material has excellent antimicrobial effect against Staphylococcus aureus. Co-culture of osteoblasts, osteoclasts and mesenchymal stem cells with the material showed that the cells were morphologically complete on the surface of the composites with good growth status. Vancomycin, bone cement and mineralized collagen composite drug-carrying biomaterials have excellent slow-release effect and antimicrobial properties with good biocompatibility, which is a new therapeutic idea for the future clinical treatment of bone defect infections.</p><p id="Par2">
<graphic position="anchor" id="d33e204" orientation="portrait" xlink:href="10856_2025_6912_Figa_HTML.jpg"/>
</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/</institution-id><institution>the key Research and Development Program Project of Ningxia Hui Autonomous Region</institution></institution-wrap></funding-source><award-id>2022BEG03089</award-id><principal-award-recipient><name name-style="western"><surname>Liu</surname><given-names>Haitao</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/http://dx.doi.org/10.13039/501100004772</institution-id><institution>Natural Science Foundation of Ningxia Province</institution></institution-wrap></funding-source><award-id>2024AAC03711</award-id><principal-award-recipient><name name-style="western"><surname>Liu</surname><given-names>Haitao</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Science+Business Media, LLC, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">In clinical work, the incidence of bone defects caused by trauma, limb deformity, tumors and infectious diseases is increasing, and large bone defects can cause great inconvenience to patients, seriously affect their postoperative recovery, and jeopardize their physical and mental health [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Bone defects are highly susceptible to bacterial infections, and post-fracture infections have become one of the most common forms of bone infections, with Staphylococcus aureus being the most common causative organism, and the incidence of post-fracture internal fixation infections can range from 0.4% to 16.1%, with an average incidence rate of about 5% [<xref ref-type="bibr" rid="CR3">3</xref>&#8211;<xref ref-type="bibr" rid="CR5">5</xref>]. Bone defects with infections can cause severe limb deformity and dysfunction if not treated in time or improperly treated. Prevention and treatment of postoperative fracture infection is urgent.</p><p id="Par4">At present, the treatment of bone defect infection is mainly based on repeated thorough debridement, negative pressure drainage and antibiotic treatment, but its treatment period is long, costly, high recurrence rate and may produce antibiotic resistance and organ toxicity damage, treatment difficulty, and extremely difficult to deal with [<xref ref-type="bibr" rid="CR6">6</xref>]. At the present stage, Polymethylmethacrylate (PMMA) bone cement with antibiotics is a simple and effective technique for repairing segmental bone defects, in which scaffolding material with antimicrobial properties is prepared by loading antibiotics and filled into the infected bone defect site [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. However, in some patients, the use of PMMA bone cement with antibiotics for the treatment of bone defects with infections did not achieve the desired therapeutic results, and sometimes the infection worsened. The possible reasons for this are the poor biosolubility of the system, the low antibiotic release rate, the short effective release time of antibiotics, and the non-biodegradable properties [<xref ref-type="bibr" rid="CR9">9</xref>]. Among them, the surface size and porosity of the bone cement are considered to be the key factors affecting the release of antibiotics from PMMA [<xref ref-type="bibr" rid="CR10">10</xref>]. Recent studies suggest that the integration of bone mineralized collagen into bone cement substantially enhances its elastic modulus [<xref ref-type="bibr" rid="CR11">11</xref>&#8211;<xref ref-type="bibr" rid="CR13">13</xref>]. Furthermore, over time, new bone tissue progressively infiltrates the porous matrix, forming as the bone mineralized collagen is absorbed. Consequently, the incorporation of bone mineralized collagen into bone cement not only preserves the inherent benefits of the cement but also addresses its limitations, such as non-degradability and non-absorbability, thereby augmenting its mechanical properties and biocompatibility.</p><p id="Par5">To address the problems of low antibiotic release rate and short effective antibiotic release time of existing PMMA-loaded antibiotics, we proposed to use mineralized collodion raw material (MC) plus bone cement (PMMA) plus vancomycin (vancomycin). We propose to use mineralized collodion raw material (MC) plus bone cement (PMMA) plus vancomycin (vancomycin) to construct MC-PMMA-vancomycin novel composites to solve the problems of low antibiotic release rate and short antibiotic effective release time. Mineralized collagen raw material, on the other hand, is a bionic composite material with collagen and hydroxyapatite as the main elements, simulating the chemical composition and microstructure of natural bone matrix. Mineralized collagen has good osteoinductive and angiogenic potential, biocompatibility, biodegradability, controllable shape and size, long shelf life and low cost [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Based on the respective advantages and disadvantages of traditional bone cement as well as mineralized collagen raw materials in clinical treatment, mineralized collagen raw materials can increase the porosity of the bone cement surface, improve the release efficiency and release time of vancomycin in the novel MC-PMMA-vancomycin composites, and provide new therapeutic ideas for the clinical treatment of bone defect infection.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Preparation of mineralized collagen raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials</title><p id="Par6">Mineralized collagen and vancomycin were mixed and shaped in a beaker, then bone cement was added, mixed and stirred well, and finally the mixture was poured into an abrasive apparatus with a length, width and height of 12&#8201;mm, waited for solidification, and taken out for spare. All instruments were pre-sterilized and should be dry at the time of use and have the same temperature (23&#8201;&#176;C&#8201;&#177;&#8201;1&#8201;&#176;C) as the overall environment of the operating room. Three groups of samples were prepared, each group of vancomycin, mineralized gum raw material and bone cement were formulated as in Table <xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Mineralized gum raw material-bone cement-vancomycin (MC-PMMA-vancomycin) ratios</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">GROUP</th><th colspan="1" rowspan="1">Mineralized collagen(g)</th><th colspan="1" rowspan="1">Polymethylmethacrylate(g)</th><th colspan="1" rowspan="1">Vancomycin(g)</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">1</td></tr></tbody></table><table-wrap-foot><p>Table 1 GROUP1 vancomycin 1&#8201;g, mineralized collagen 2&#8201;g, bone cement 13&#8201;g. GROUP2 vancomycin 1&#8201;g, mineralized collagen 1&#8201;g, bone cement 13&#8201;g. GROUP3 vancomycin 1&#8201;g, bone cement 13&#8201;g</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4"><title>Scanning electron microscopy analysis of mineralized gum material raw material-bone cement-vancomycin (mc-pmma-vancomycin) biomaterials</title><p id="Par7">We performed scanning electron microscopy experiments on the samples using a scanning electron microscope (Japan Electronics (JEOL), JSM-IT700HR) and an ion sputtering apparatus (Japan Electronics (JEOL), Smart Coater). The samples were first washed with PBS to remove surface adherents and mucus, etc., and 3% glutaraldehyde was added for fixation, after which the samples were washed with ultrapure water for 3 times, 10&#8201;min each time, and then fixed with 1% osmium acid for 1&#8201;h-2&#8201;h, and then washed with ultrapure water for 3 times, 10&#8201;min each time. The samples were dehydrated by alcohol step by step, and the concentration of the dehydrating agent gradient was 30%&#8201;&#8594;&#8201;50%&#8201;&#8594;&#8201;70%&#8201;&#8594;&#8201;90%&#8201;&#8594;&#8201;100% (100% concentration was exchanged for 3 times), 15&#8201;min each time; the samples were removed from the sample and then washed by alcohol.), 15&#8201;min each time; the sample was put into the critical point dryer for drying and then glued to the sample stage with conductive adhesive, and put into the ion sputtering instrument for gold spraying. Finally, the use of Japan Electronics Corporation (JEOL) production of JSM-IT700HR scanning electron microscope for image acquisition of samples, each sample first in the low magnification to observe the whole sample, and then select the region to be observed to collect pictures.</p></sec><sec id="Sec5"><title>Drug retardation test ofmineralized collodion raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials</title><p id="Par8">We used High Performance Liquid Chromatography\HPLC analysis system to perform drug slow release test on the samples. The chromatographic conditions of vancomycin were as follows: column: Hypersil ODS2 (250&#8201;mm&#8201;&#215;&#8201;4.6&#8201;mm, 5&#8201;&#956;m); mobile phase: acetonitrile-50 mmol of potassium dihydrogen phosphate solution (pH&#8201;=&#8201;3.2 adjusted by phosphoric acid) =10:90 (see Fig. <xref rid="Fig2" ref-type="fig">2A</xref>); flow rate: 1.0&#8201;mL-min-1; column temperature: 30&#8201;&#176;C; detection wavelength: 236&#8201;nm; injection volume: 20&#8201;&#956;L. Under this chromatographic condition, the retention time of vancomycin was in the range of 6&#8211;7&#8201;min. The linear regression of peak area (A) on mass concentration (C) gave the standard curve equation A = y&#8201;=&#8201;16087*C&#8201;+&#8201;2786.8, r&#8201;=&#8201;1 (<italic toggle="yes">n</italic>&#8201;=&#8201;6), which showed that vancomycin had a good linear relationship in the range of 1&#8211;100&#8201;&#956;g-mL-1. Finally, the in vitro release of the samples was assayed by simulating the human physiological environment pH 7.4 phosphate buffer as the release medium. The samples were transferred into a conical flask containing 40&#8201;ml of release medium and shaken at 37&#8201;&#176;C and 100&#8201;r/min. A 2&#8201;mL sample was taken at the set time point and an equal volume of release medium was added. The sample solution was filtered through a microporous membrane (0.45&#8201;&#956;m), and the content was detected by HPLC, and the cumulative release of vancomycin was calculated and plotted as a release curve.</p></sec><sec id="Sec6"><title>In vitro antimicrobial experiments of mineralized adhesive raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials</title><p id="Par9">We conducted in vitro antimicrobial experiments against Staphylococcus aureus and Pseudomonas aeruginosa on mineralized gum raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials. Firstly, 100&#8201;&#956;L of glycerol bacteria were taken and coated into LB agar medium and incubated at 37&#8201;&#176;C for 24&#8201;h. Single colonies were picked and inoculated into LB broth and incubated for 16&#8201;h at 37&#8201;&#176;C with 150&#8201;rpm oscillation for bacterial culture. Next, the bacterial concentration was determined by using the McDonald&#8217;s turbidimetric method, and the concentration of the bacterial solution was adjusted to 1&#8201;&#215;&#8201;108 CFU/mL using sterile liquid medium, and the bacterial solution was set aside.</p><p id="Par10">Finally, 200&#8201;&#181;L of 108 CFU/mL bacterial solution was aspirated on LB agar culture, and each plate was placed with a bottom-containing drug plaster block (the drug was melted with saline and coated to the bottom of the plaster block), and the effect of bacterial inhibition was observed at 37&#8201;&#176;C to detect the circle of inhibition.</p></sec><sec id="Sec7"><title>In vitro co-culture of MC-PMMA-vancomycin biomaterials with mouse osteoblast cell line MC3T3-E1, mouse RAW256.7 cells, and rabbit primary mesenchymal stem cells</title><p id="Par11">We co-cultured mouse osteoblast cell line (MC3T3-E1), mouse RAW256.7 cells and rabbit primary MSCs in vitro with mineralized collagen raw material-cement-vancomycin (MC-PMMA-vancomycin) biomaterial. Firstly, after PBS washed the medium adequately, trypsin digested moderately and then each cell line, inoculated at a density of 50,000/cell in a 6-well culture chamber for cultivation; the culture medium was changed every 3 days, and after 5 days of cultivation, mineralized collagen raw material-cemented bone-vancomycin (MC-PMMA-vancomycin) biomaterials were added to the medium, and the materials were taken from the culture and put into the culture of the 6-well culture chamber after one week of continued cultivation. Scanning electron microscopy was performed after fixation in electron microscope fixative, and the remaining liquid in the culture medium was subjected to CCK-8 assay. Remove the cell supernatant, add the serum-containing medium containing CCK-8 reagent, and put it in 37&#8201;&#176;C, 5% (v/v) CO2 incubator for 2&#8211;4&#8201;h, then take it out to measure the absorbance value, and repeat the measurement 3 times for each sample to take the average value.</p></sec></sec><sec id="Sec8" sec-type="results"><title>Results</title><sec id="Sec9"><title>Scanning electron microscopy experimental results of mineralized gum raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials</title><p id="Par12">We carried out scanning electron microscope experiments on all four sides of the three groups of cubic samples prepared, and the results showed that in the samples with the addition of mineralized gum raw material, obvious voids on the surface of bone cement could be observed, and no voids were seen on the surface of the material in the bone cement alone group (without the addition of mineralized gum raw material). The results are shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p><bold>A</bold> GROUP1 (vancomycin 1&#8201;g, mineralized collagen 2&#8201;g, bone cement 13&#8201;g) Scanning electron microscope experimental results, more voids exist on the surface of the material. <bold>B</bold> GROUP2 (vancomycin 1&#8201;g, mineralized collagen 1&#8201;g, bone cement 13&#8201;g) Scanning electron microscope experimental results, the surface of the material did not see any obvious voids. <bold>C</bold> GROUP3 (vancomycin 1&#8201;g, bone cement 13&#8201;g) Scanning electron microscope experiment results, no obvious voids were seen on the surface of the material</p></caption><graphic id="d33e362" position="float" orientation="portrait" xlink:href="10856_2025_6912_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec10"><title>Results of drug retardation of mineralized collagen raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials</title><p id="Par13">We used High Performance Liquid Chromatography\HPLC. The results showed that the GROUP1 (vancomycin 1&#8201;g, mineralized collagen 2&#8201;g, bone cement 13&#8201;g) group had good release efficiency and release time, releasing 26.3% of the drug on the first day, and then 45.6% on the 14th day, and stabilizing. The GROUP2 (vancomycin 1&#8201;g, mineralized collagen 1&#8201;g, bone cement 13&#8201;g) group released 16% of the drug on the first day. Cement 13&#8201;g) group released 16% of the drug on the first day and reached 46.5% on the 38th day. GROUP3 (Vancomycin 1&#8201;g, Bone Cement 13&#8201;g) group had the worst efficiency of drug release, releasing 8.5% of the drug on the first day and reaching only 19.1% on the 38th day. The results are shown in Table <xref rid="Tab2" ref-type="table">2</xref> and Fig. <xref rid="Fig2" ref-type="fig">2</xref>. Mineralized collagen raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterial can increase the porosity of the bone cement surface, which increases the release stoichiometry and efficiency of antibiotics.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Results of drug slow release of mineralized gum raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">days</th><th colspan="1" rowspan="1">Group1 Cumulative release (%)</th><th colspan="1" rowspan="1">Group2 Cumulative release (%)</th><th colspan="1" rowspan="1">Group3 Cumulative release (%)</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">26.3</td><td colspan="1" rowspan="1">16.0</td><td colspan="1" rowspan="1">8.5</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">31.2</td><td colspan="1" rowspan="1">19.1</td><td colspan="1" rowspan="1">9.2</td></tr><tr><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">34.7</td><td colspan="1" rowspan="1">21.5</td><td colspan="1" rowspan="1">10.0</td></tr><tr><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">36.9</td><td colspan="1" rowspan="1">24.6</td><td colspan="1" rowspan="1">10.4</td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">38.8</td><td colspan="1" rowspan="1">25.8</td><td colspan="1" rowspan="1">10.9</td></tr><tr><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">40.5</td><td colspan="1" rowspan="1">27.2</td><td colspan="1" rowspan="1">11.0</td></tr><tr><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">41.0</td><td colspan="1" rowspan="1">29.4</td><td colspan="1" rowspan="1">11.9</td></tr><tr><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">43.9</td><td colspan="1" rowspan="1">33.4</td><td colspan="1" rowspan="1">13.2</td></tr><tr><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">44.8</td><td colspan="1" rowspan="1">35.2</td><td colspan="1" rowspan="1">13.8</td></tr><tr><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">45.6</td><td colspan="1" rowspan="1">37.4</td><td colspan="1" rowspan="1">14.2</td></tr><tr><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">46.1</td><td colspan="1" rowspan="1">38.0</td><td colspan="1" rowspan="1">14.7</td></tr><tr><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">47.2</td><td colspan="1" rowspan="1">43.7</td><td colspan="1" rowspan="1">17.0</td></tr><tr><td colspan="1" rowspan="1">38</td><td colspan="1" rowspan="1">47.9</td><td colspan="1" rowspan="1">46.5</td><td colspan="1" rowspan="1">19.1</td></tr></tbody></table></table-wrap><fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Results of drug slow release of mineralized collagen material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials. <bold>A</bold> Standard curve of vancomycin release. <bold>B</bold> GROUP1 (vancomycin 1&#8201;g, mineralized collagen 2&#8201;g, bone cement 13&#8201;g) drug release curve on the first day and the fourteenth day. <bold>C</bold> GROUP2 (vancomycin 1&#8201;g, mineralized collagen 1&#8201;g, bone cement 13&#8201;g) drug day one, day fourteen release profile. <bold>D</bold> GROUP3 (vancomycin 1&#8201;g, bone cement 13&#8201;g) drug day one, day fourteen release profile. <bold>E</bold> Comparison of release profiles of vancomycin in the three groups of samples</p></caption><graphic id="d33e534" position="float" orientation="portrait" xlink:href="10856_2025_6912_Fig2_HTML.jpg"/></fig></p></sec><sec id="Sec11"><title>Antibacterial experimental results of mineralized glue raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials</title><p id="Par14">We conducted in vitro antibacterial experiments on mineralized gum raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials against Staphylococcus aureus and Pseudomonas aeruginosa, and the results showed that all three groups of samples had excellent antibacterial effects against Staphylococcus aureus, but no antibacterial effects against Pseudomonas aeruginosa because vancomycin itself has no antibacterial effect on Pseudomonas aeruginosa, and we set up samples against Pseudomonas aeruginosa can be antibacterial experiments. effect, the antimicrobial experiment of our established samples against Pseudomonas aeruginosa can be used as a control group for the antimicrobial experiment. The results of the antimicrobial experiments are shown in Tables <xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref> and Fig. <xref rid="Fig3" ref-type="fig">3</xref>.<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Results of Staphylococcus aureus inhibition circle of mineralized gum raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Time (h)</th><th colspan="6" rowspan="1">Diameter of the bacteriostatic zone (mm)</th></tr><tr><th colspan="2" rowspan="1">Group1</th><th colspan="2" rowspan="1">Group2</th><th colspan="2" rowspan="1">Group3</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">0&#8201;h</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">/</td></tr><tr><td colspan="1" rowspan="1">16&#8201;h</td><td colspan="1" rowspan="1">24.8</td><td colspan="1" rowspan="1">23.6</td><td colspan="1" rowspan="1">23.5</td><td colspan="1" rowspan="1">22.7</td><td colspan="1" rowspan="1">23.4</td><td colspan="1" rowspan="1">25.2</td></tr><tr><td colspan="1" rowspan="1">24&#8201;h</td><td colspan="1" rowspan="1">24.2</td><td colspan="1" rowspan="1">23.4</td><td colspan="1" rowspan="1">22.6</td><td colspan="1" rowspan="1">23.5</td><td colspan="1" rowspan="1">25.0</td><td colspan="1" rowspan="1">23.4</td></tr><tr><td colspan="1" rowspan="1">40&#8201;h</td><td colspan="1" rowspan="1">24.6</td><td colspan="1" rowspan="1">23.4</td><td colspan="1" rowspan="1">23.7</td><td colspan="1" rowspan="1">22.6</td><td colspan="1" rowspan="1">23.5</td><td colspan="1" rowspan="1">25.1</td></tr><tr><td colspan="1" rowspan="1">48&#8201;h</td><td colspan="1" rowspan="1">23.8</td><td colspan="1" rowspan="1">24.4</td><td colspan="1" rowspan="1">23.6</td><td colspan="1" rowspan="1">22.5</td><td colspan="1" rowspan="1">23.3</td><td colspan="1" rowspan="1">25.4</td></tr></tbody></table></table-wrap><table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>nhibition circle results of Pseudomonas aeruginosa in mineralized gum raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Time (h)</th><th colspan="6" rowspan="1">Diameter of the bacteriostatic zone (mm)</th></tr><tr><th colspan="2" rowspan="1">Group1</th><th colspan="2" rowspan="1">Group2</th><th colspan="2" rowspan="1">Group3</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">0&#8201;h</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">/</td><td colspan="1" rowspan="1">/</td></tr><tr><td colspan="1" rowspan="1">16&#8201;h</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">24&#8201;h</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">40&#8201;h</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">48&#8201;h</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr></tbody></table></table-wrap><fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p><bold>A</bold> Mineralized gum raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterial anti-Pseudomonas aeruginosa experimental results, all three groups of samples have no bacteriostatic effect on Pseudomonas aeruginosa. <bold>B</bold> The results of anti-Staphylococcus aureus experiments of mineralized gum raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterials showed that all three groups of samples had no bacteriostatic effect on Staphylococcus aureus</p></caption><graphic id="d33e764" position="float" orientation="portrait" xlink:href="10856_2025_6912_Fig3_HTML.jpg"/></fig></p></sec><sec id="Sec12"><title>Results of in vitro co-culture of MC-PMMA-vancomycin biomaterials with mouse osteoblast cell line MC3T3-E1, mouse RAW256.7 cells, and rabbit primary mesenchymal stem cells (BMSCs)</title><p id="Par15">We validated the biocompatibility of mineralized collodion raw material-cement-vancomycin (MC-PMMA-vancomycin) biomaterials in vitro co-cultured with mouse osteoblast cell line MC3T3-E1, and the biocompatibility of the materials was verified at the level of the osteoblast cell line MC3T3-E1 by the CCK-8 assay, and the results showed that the mineralized collodion raw material-cement-vancomycin (MC-PMMA) biomaterials are not compatible with the mouse osteoblast cell line MC3T3-E1. PMMA-vancomycin) biomaterials had good biocompatibility with osteoblast cell line MC3T3-E1. Scanning electron microscopy results showed that all groups of cells grew well in the cell state on the surface of the three sample groups. The results are shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>.<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><p><bold>A</bold> Mouse osteoblast cell line (MC3T3-E1) growth on the surface of mineralized glue raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterial, cell morphology is intact and in good condition B: Rabbit primary mesenchymal stem cell (BMSC) growth on the surface of mineralized glue raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterial, cell morphology is intact and in good condition. <bold>B</bold> rabbit primary mesenchymal stem cells (BMSC) grown on the surface of mineralized glue raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterial, cell morphology is intact and in good condition. <bold>C</bold> mouse RAW256.7 cells grown on the surface of mineralized glue raw material-bone cement-vancomycin (MC-PMMA-vancomycin) biomaterial, cell morphology is intact and in good condition. <bold>D</bold> Cell viability (%) of MC3T3-E1 on MC-PMMA-vancomycin. <bold>E</bold> Cell viability (%) of BMSC on MC-PMMA-vancomycin. <bold>F</bold> Cell viability (%) of RAW256.7 on MC-PMMA-vancomycin.</p></caption><graphic id="d33e796" position="float" orientation="portrait" xlink:href="10856_2025_6912_Fig4_HTML.jpg"/></fig></p></sec></sec><sec id="Sec13" sec-type="discussion"><title>Discussion</title><p id="Par16">The treatment of infected bone defects has always been a thorny problem for orthopedic surgeons, and anti-infective tissue-engineered bone is currently the most promising graft material for repairing infected bone defects, in which one of the very key techniques is the use of local antibiotic release system [<xref ref-type="bibr" rid="CR16">16</xref>]. PMMA bone cement as the most commonly used antibiotic carriers has been widely used in domestic and international clinical treatment. However, PMMA combined with antibiotics has the problems of low release rate, short effective release time and non-biodegradable characteristics [<xref ref-type="bibr" rid="CR17">17</xref>]. There is an urgent need to develop scaffold materials with good slow-release effect, good biocompatibility, and high efficiency antibacterial materials that are not easy to develop bacterial resistance for the treatment of infected bone defects, and to realize simultaneous treatment of antibacterial and bone repair. How to improve the shortcomings of PMMA bone cement as an orthopedic material has become one of the hot areas of biomaterials research in recent years.</p><p id="Par17">The release of antibiotics in bone cement is a diffusion process, and this process is affected by several factors. The surface size and porosity of bone cement are considered to be the key factors affecting the release of antibiotics from PMMA. Duey et al. conducted a comparative study on the release of Van and tobramycin from Simplex bone cement with different shapes and volumes, and the results showed that the amount of antibiotics released was not significantly related to the volume of the bone cement, but rather there was a significant linear positive correlation with its surface area [<xref ref-type="bibr" rid="CR18">18</xref>]. This finding was also confirmed by Masri et al. [<xref ref-type="bibr" rid="CR19">19</xref>]. This is because the elution of antibiotics occurs mainly in the outer layer of the bone cement, and therefore, the size of the surface area has an important influence on the efficiency of antibiotic release. Schurman et al. showed that the release of antibiotics occurs mainly in the superficial 100&#8201;&#181;m layer, and only 19% of the antibiotics were released from the deeper 700&#8201;&#181;m layer [<xref ref-type="bibr" rid="CR20">20</xref>]. Therefore, the shape of the bone cement should be rationally designed to increase the porosity of its surface according to the specific clinical needs and surgical requirements, so as to improve the release efficiency of antibiotics.</p><p id="Par18">Previous researchers have added specific bioactive substances (e.g., chitosan, bioactive ceramics, graphene, etc.) to PMMA to enhance osteogenesis and antimicrobial substances (e.g., metal ions and antimicrobial peptides) to enhance antimicrobial capacity [<xref ref-type="bibr" rid="CR21">21</xref>]. Due to the complexity of the manufacturing process or biosafety issues of the materials in previous studies, there is still a large gap between them and clinical translation. Better material improvement solutions are still needed to solve the existing problems and meet the clinical needs. Mineralized collagen materials can meet these requirements. Mineralized collagen is an important protein in many animal tissues, such as skin, bone, ligament, tendon and cartilage. Therefore collagen materials play an important role in the solution of many tissue engineering problems such as repair and reconstruction of tissues, bone and skin [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Xing Fei et al. used composite scaffolds prepared from raw materials including mineralized collagen materials and demonstrated that they can promote cell differentiation and thus osteogenesis, and also have good biodegradability as well as mechanical properties [<xref ref-type="bibr" rid="CR23">23</xref>]. In recent years, mineralized collagen artificial bone repair materials have been used for filling and regenerative repair of various types of bone defects in surgery, and good clinical results have been achieved [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par19">In this experiment, vancomycin, bone cement (PMMA) and mineralized collagen (MC) will be mixed in order to obtain a new composite drug-carrying biomaterial, using electron microscope scanning to analyze the surface of the new material found that in the samples with the addition of the mineralized collagen raw material, it can be observed that there is a clear void on the surface of the bone cement, and the surface of the material of the bone cement alone group (without the addition of the mineralized collagen raw material) did not see any void, which may be the This may be the reason for the better drug release efficiency of the new composites. In addition to this, we also conducted in vitro antibacterial experiments on the new composite material, which proved that the new material has excellent antibacterial performance against Staphylococcus aureus in vitro. Co-culture experiments with mouse osteoblast cell line (MC3T3-E1), mouse RAW256.7 cells and rabbit primary mesenchymal stem cells (BMSC) also demonstrated the excellent cytocompatibility of the new composites.</p><p id="Par20">Limitations of the study: This experiment also has some limitations, we chose to adopt the commonly used materials that have received general acceptance, mineralized collagen plus bone cement combined with vancomycin-loaded drug for the experiment, and did not conduct experiments on other materials, missing some potential materials for the treatment of infection in bone defects, and our subsequent experiments can be tried on other materials. Also affected by the experimental time and funding, we regret that we did not carry out in vivo animal experiments to verify the experimental results, and we will follow up with in vivo animal experiments.</p></sec><sec id="Sec14" sec-type="conclusion"><title>Conclusion</title><p id="Par21">The composite drug-carrying biomaterial of vancomycin, bone cement and mineralized collagen has excellent slow-release effect and antimicrobial properties with good biocompatibility, which is a new therapeutic idea for the future clinical treatment of bone defect infection.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>Haitao Liu: Funding acquisition, Writing-original draft, Writing-review &amp; editing. Yu Bo: Formal analysis, Methodology, Data curation. Pengcheng Gao: Formal analysis, Methodology, Data curation. Zhizhong Li: Formal analysis, Methodology, Data curation. Shaodong Qiu: Formal analysis, Methodology, Data curation. Gangning Feng: Formal analysis, Methodology, Data curation. Zongqiang Yang: Formal analysis, Methodology, Data curation. He Zhang: Formal analysis, Methodology, Data curation. Zhanhu Mi: Conceptualization, Writing-review &amp; editing. All authors analysed and interpreted the data. The author (s) read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The work was supported by the key Research and Development Program Project of Ningxia Hui Autonomous Region (No. 2022BEG03089), Natural Science Foundation of Ningxia Province (No. 2024AAC03711). The funding agency did not participate in the study&#8217;s design, data collection, analysis, or interpretation, nor in the preparation of the manuscript.</p></notes><notes notes-type="ethics"><title>Compliance with ethical standards</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par22">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Cooke ME, Tornetta P, 3rd, Firoozabadi R, Vallier H, Weinberg DS.Alton TB, et al. Open Ankle Fractures: What Predicts Infection? A Multicenter Study. J Orthop Trauma. 2021;36:43&#8211;48.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/BOT.0000000000002293</pub-id><pub-id pub-id-type="pmid">34711768</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yong-Cheol</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hyung Keun</surname><given-names>S</given-names></name><name name-style="western"><surname>Jong Seong</surname><given-names>H</given-names></name><name name-style="western"><surname>Kyung Cheon</surname><given-names>L</given-names></name></person-group><article-title>Antegrade nailing in femoral shaft fracture patients - comparison of outcomes of isolated fractures, multiple fractures and severely injured patients</article-title><source>Injury</source><year>2021</year><volume>52</volume><fpage>3068</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">33563415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.injury.2021.01.044</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Yong-Cheol Y, Hyung Keun S, Jong Seong H, Kyung Cheon L. Antegrade nailing in femoral shaft fracture patients - comparison of outcomes of isolated fractures, multiple fractures and severely injured patients. Injury. 2021;52:3068&#8211;74.<pub-id pub-id-type="pmid">33563415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.injury.2021.01.044</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriarty</surname><given-names>TF</given-names></name><name name-style="western"><surname>Metsemakers</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Morgenstern</surname><given-names>M</given-names></name><name name-style="western"><surname>Hofstee</surname><given-names>MI</given-names></name><name name-style="western"><surname>Vallejo Diaz</surname><given-names>A</given-names></name><name name-style="western"><surname>Cassat</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Fracture-related infection</article-title><source>Nat Rev Dis Prim</source><year>2022</year><volume>8</volume><fpage>67.</fpage><pub-id pub-id-type="pmid">36266296</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41572-022-00396-0</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Moriarty TF, Metsemakers WJ, Morgenstern M, Hofstee MI, Vallejo Diaz A, Cassat JE, et al. Fracture-related infection. Nat Rev Dis Prim 2022;8:67.<pub-id pub-id-type="pmid">36266296</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41572-022-00396-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baertl</surname><given-names>S</given-names></name><name name-style="western"><surname>Metsemakers</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Morgenstern</surname><given-names>M</given-names></name><name name-style="western"><surname>Alt</surname><given-names>V</given-names></name><name name-style="western"><surname>Richards</surname><given-names>RG</given-names></name><name name-style="western"><surname>Moriarty</surname><given-names>TF</given-names></name><etal/></person-group><article-title>Fracture-related infection</article-title><source>Bone Jt Res</source><year>2021</year><volume>10</volume><fpage>351</fpage><lpage>3</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1302/2046-3758.106.BJR-2021-0167.R1</pub-id><pub-id pub-id-type="pmcid">PMC8242679</pub-id><pub-id pub-id-type="pmid">34076501</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Baertl S, Metsemakers WJ, Morgenstern M, Alt V, Richards RG, Moriarty TF, et al. Fracture-related infection. Bone Jt Res. 2021;10:351&#8211;3.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1302/2046-3758.106.BJR-2021-0167.R1</pub-id><pub-id pub-id-type="pmcid">PMC8242679</pub-id><pub-id pub-id-type="pmid">34076501</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rupp</surname><given-names>M</given-names></name><name name-style="western"><surname>Walter</surname><given-names>N</given-names></name><name name-style="western"><surname>B&#228;rtl</surname><given-names>S</given-names></name><name name-style="western"><surname>Heyd</surname><given-names>R</given-names></name><name name-style="western"><surname>Hitzenbichler</surname><given-names>F</given-names></name><name name-style="western"><surname>Alt</surname><given-names>V</given-names></name></person-group><article-title>Fracture-related infection-epidemiology, etiology, diagnosis, prevention, and treatment</article-title><source>Dtsch Arzteblatt Int</source><year>2024</year><volume>121</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3238/arztebl.m2023.0233</pub-id><pub-id pub-id-type="pmcid">PMC10916768</pub-id><pub-id pub-id-type="pmid">37970721</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Rupp M, Walter N, B&#228;rtl S, Heyd R, Hitzenbichler F, Alt V. Fracture-related infection-epidemiology, etiology, diagnosis, prevention, and treatment. Dtsch Arzteblatt Int. 2024;121:17&#8211;24.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3238/arztebl.m2023.0233</pub-id><pub-id pub-id-type="pmcid">PMC10916768</pub-id><pub-id pub-id-type="pmid">37970721</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wen</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name></person-group><article-title>Bone transport versus acute shortening for the management of infected tibial bone defects: a meta-analysis</article-title><source>BMC Musculoskelet Disord</source><year>2020</year><volume>21</volume><fpage>80.</fpage><pub-id pub-id-type="pmid">32028924</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12891-020-3114-y</pub-id><pub-id pub-id-type="pmcid">PMC7006089</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Wen H, Zhu S, Li C, Xu Y. Bone transport versus acute shortening for the management of infected tibial bone defects: a meta-analysis. BMC Musculoskelet Disord. 2020;21:80.<pub-id pub-id-type="pmid">32028924</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12891-020-3114-y</pub-id><pub-id pub-id-type="pmcid">PMC7006089</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lalidou</surname><given-names>F</given-names></name><name name-style="western"><surname>Kolios</surname><given-names>G</given-names></name><name name-style="western"><surname>Drosos</surname><given-names>G</given-names></name></person-group><article-title>Bone infections and bone graft substitutes for local antibiotic therapy</article-title><source>Surgical Technol Int</source><year>2014</year><volume>24</volume><fpage>353</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">24504740</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Lalidou F, Kolios G, Drosos G. Bone infections and bone graft substitutes for local antibiotic therapy. Surgical Technol Int. 2014;24:353&#8211;62.<pub-id pub-id-type="pmid">24504740</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>R</given-names></name><name name-style="western"><surname>Long</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>C</given-names></name><etal/></person-group><article-title>Advances in the Masquelet technique: Myeloid-derived suppressor cells promote angiogenesis in PMMA-induced membranes</article-title><source>Acta Biomater</source><year>2020</year><volume>108</volume><fpage>223</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">32165192</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2020.03.010</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Wang W, Zuo R, Long H, Wang Y, Zhang Y, Sun C, et al. Advances in the Masquelet technique: Myeloid-derived suppressor cells promote angiogenesis in PMMA-induced membranes. Acta Biomater. 2020;108:223&#8211;36.<pub-id pub-id-type="pmid">32165192</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2020.03.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frutos</surname><given-names>G</given-names></name><name name-style="western"><surname>Pastor</surname><given-names>J</given-names></name><name name-style="western"><surname>Mart&#237;nez</surname><given-names>N</given-names></name><name name-style="western"><surname>Virto</surname><given-names>M</given-names></name><name name-style="western"><surname>Torrado</surname><given-names>S</given-names></name></person-group><article-title>Influence of lactose addition to gentamicin-loaded acrylic bone cement on the kinetics of release of the antibiotic and the cement properties</article-title><source>Acta Biomater</source><year>2010</year><volume>6</volume><fpage>804</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">19703595</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2009.08.028</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Frutos G, Pastor J, Mart&#237;nez N, Virto M, Torrado S. Influence of lactose addition to gentamicin-loaded acrylic bone cement on the kinetics of release of the antibiotic and the cement properties. Acta Biomater. 2010;6:804&#8211;11.<pub-id pub-id-type="pmid">19703595</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2009.08.028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Nogueira</surname><given-names>LP</given-names></name><name name-style="western"><surname>Haugen</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Van Der Geest</surname><given-names>IC</given-names></name><name name-style="western"><surname>de Almeida Rodrigues</surname><given-names>PC</given-names></name><name name-style="western"><surname>Janssen</surname><given-names>D</given-names></name><etal/></person-group><article-title>Dual-functional porous and cisplatin-loaded polymethylmethacrylate cement for reconstruction of load-bearing bone defect kills bone tumor cells</article-title><source>Bioact Mater</source><year>2022</year><volume>15</volume><fpage>120</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">35386344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioactmat.2021.12.023</pub-id><pub-id pub-id-type="pmcid">PMC8941180</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Wang Z, Nogueira LP, Haugen HJ, Van Der Geest IC, de Almeida Rodrigues PC, Janssen D, et al. Dual-functional porous and cisplatin-loaded polymethylmethacrylate cement for reconstruction of load-bearing bone defect kills bone tumor cells. Bioact Mater. 2022;15:120&#8211;30.<pub-id pub-id-type="pmid">35386344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioactmat.2021.12.023</pub-id><pub-id pub-id-type="pmcid">PMC8941180</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Comparison of human mesenchymal stem cells proliferation and differentiation on poly(methyl methacrylate) bone cements with and without mineralized collagen incorporation</article-title><source>J Biomater Appl</source><year>2015</year><volume>30</volume><fpage>722</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">25899928</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0885328215582112</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Wu J, Xu S, Qiu Z, Liu P, Liu H, Yu X, et al. Comparison of human mesenchymal stem cells proliferation and differentiation on poly(methyl methacrylate) bone cements with and without mineralized collagen incorporation. J Biomater Appl 2015;30:722&#8211;31.<pub-id pub-id-type="pmid">25899928</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0885328215582112</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>L</given-names></name><name name-style="western"><surname>Xisheng</surname><given-names>W</given-names></name><name name-style="western"><surname>Yanyan</surname><given-names>B</given-names></name><name name-style="western"><surname>Lei</surname><given-names>Z</given-names></name><name name-style="western"><surname>Fuzhai</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhiye</surname><given-names>Q</given-names></name></person-group><article-title>Influence of Nano-HA Coated Bone Collagen to Acrylic (Polymethylmethacrylate) Bone Cement on Mechanical Properties and Bioactivity</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>0129018.</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0129018</pub-id><pub-id pub-id-type="pmcid">PMC4454564</pub-id><pub-id pub-id-type="pmid">26039750</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Tao L, Xisheng W, Yanyan B, Lei Z, Fuzhai C, Zhiye Q. Influence of Nano-HA Coated Bone Collagen to Acrylic (Polymethylmethacrylate) Bone Cement on Mechanical Properties and Bioactivity. PLoS One. 2015;10:0129018.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0129018</pub-id><pub-id pub-id-type="pmcid">PMC4454564</pub-id><pub-id pub-id-type="pmid">26039750</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ming</surname><given-names>B</given-names></name><name name-style="western"><surname>Heping</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jian</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Yongdong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yimin</surname><given-names>W</given-names></name></person-group><article-title>Application of PMMA bone cement composited with bone-mineralized collagen in percutaneous kyphoplasty</article-title><source>Regen Biomater</source><year>2017</year><volume>4</volume><fpage>251</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">28798871</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rb/rbx019</pub-id><pub-id pub-id-type="pmcid">PMC5544907</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Ming B, Heping Y, Jian Z, Yang L, Yongdong Y, Yimin W. Application of PMMA bone cement composited with bone-mineralized collagen in percutaneous kyphoplasty. Regen Biomater. 2017;4:251&#8211;5.<pub-id pub-id-type="pmid">28798871</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rb/rbx019</pub-id><pub-id pub-id-type="pmcid">PMC5544907</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>G</given-names></name><name name-style="western"><surname>Bao</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Song</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fei</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Nanomaterial-based scaffolds for bone tissue engineering and regeneration</article-title><source>Nanomed</source><year>2020</year><volume>15</volume><fpage>1995</fpage><lpage>2017</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2217/nnm-2020-0112</pub-id><pub-id pub-id-type="pmid">32812486</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ye G, Bao F, Zhang X, Song Z, Liao Y, Fei Y, et al. Nanomaterial-based scaffolds for bone tissue engineering and regeneration. Nanomed. 2020;15:1995&#8211;2017.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2217/nnm-2020-0112</pub-id><pub-id pub-id-type="pmid">32812486</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wubneh</surname><given-names>A</given-names></name><name name-style="western"><surname>Tsekoura</surname><given-names>E</given-names></name><name name-style="western"><surname>Ayranci</surname><given-names>C</given-names></name><name name-style="western"><surname>Uluda&#287;</surname><given-names>H</given-names></name></person-group><article-title>Current state of fabrication technologies and materials for bone tissue engineering</article-title><source>Acta Biomater</source><year>2018</year><volume>80</volume><fpage>1</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">30248515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2018.09.031</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Wubneh A, Tsekoura E, Ayranci C, Uluda&#287; H. Current state of fabrication technologies and materials for bone tissue engineering. Acta Biomater. 2018;80:1&#8211;30.<pub-id pub-id-type="pmid">30248515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2018.09.031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Loughlin</surname><given-names>CT</given-names></name><name name-style="western"><surname>Miller</surname><given-names>L</given-names></name><name name-style="western"><surname>Siryaporn</surname><given-names>A</given-names></name><name name-style="western"><surname>Drescher</surname><given-names>K</given-names></name><name name-style="western"><surname>Semmelhack</surname><given-names>M</given-names></name><name name-style="western"><surname>Bassler</surname><given-names>B</given-names></name></person-group><article-title>A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>17981</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">24143808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1316981110</pub-id><pub-id pub-id-type="pmcid">PMC3816427</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">O'Loughlin CT, Miller L, Siryaporn A, Drescher K, Semmelhack M, Bassler B. A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. Proc Natl Acad Sci USA. 2013;110:17981&#8211;6.<pub-id pub-id-type="pmid">24143808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1316981110</pub-id><pub-id pub-id-type="pmcid">PMC3816427</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>S</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>T</given-names></name><name name-style="western"><surname>Long</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Luo</surname><given-names>L</given-names></name><etal/></person-group><article-title>A dual PMMA/calcium sulfate carrier of vancomycin is more effective than PMMA-vancomycin at inhibiting Staphylococcus aureus growth in vitro</article-title><source>FEBS Open Bio</source><year>2020</year><volume>10</volume><fpage>552</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">32052585</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/2211-5463.12809</pub-id><pub-id pub-id-type="pmcid">PMC7137790</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Luo S, Jiang T, Long L, Yang Y, Yang X, Luo L, et al. A dual PMMA/calcium sulfate carrier of vancomycin is more effective than PMMA-vancomycin at inhibiting Staphylococcus aureus growth in vitro. FEBS Open Bio. 2020;10:552&#8211;60.<pub-id pub-id-type="pmid">32052585</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/2211-5463.12809</pub-id><pub-id pub-id-type="pmcid">PMC7137790</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wright</surname><given-names>Z</given-names></name><name name-style="western"><surname>Pandit</surname><given-names>A</given-names></name><name name-style="western"><surname>Karpinsky</surname><given-names>M</given-names></name><name name-style="western"><surname>Holt</surname><given-names>B</given-names></name><name name-style="western"><surname>Zovinka</surname><given-names>E</given-names></name><name name-style="western"><surname>Sydlik</surname><given-names>S</given-names></name></person-group><article-title>Bioactive, Ion-releasing PMMA bone cement filled with functional graphenic materials</article-title><source>Adv Health Mater</source><year>2021</year><volume>10</volume><fpage>2001189.</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adhm.202001189</pub-id><pub-id pub-id-type="pmid">33326158</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Wright Z, Pandit A, Karpinsky M, Holt B, Zovinka E, Sydlik S. Bioactive, Ion-releasing PMMA bone cement filled with functional graphenic materials. Adv Health Mater. 2021;10:2001189.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adhm.202001189</pub-id><pub-id pub-id-type="pmid">33326158</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arakha</surname><given-names>M</given-names></name><name name-style="western"><surname>Pal</surname><given-names>S</given-names></name><name name-style="western"><surname>Samantarrai</surname><given-names>D</given-names></name><name name-style="western"><surname>Panigrahi</surname><given-names>TK</given-names></name><name name-style="western"><surname>Mallick</surname><given-names>BC</given-names></name><name name-style="western"><surname>Pramanik</surname><given-names>K</given-names></name><etal/></person-group><article-title>Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface</article-title><source>Sci Rep.</source><year>2015</year><volume>5</volume><fpage>14813.</fpage><pub-id pub-id-type="pmid">26437582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep14813</pub-id><pub-id pub-id-type="pmcid">PMC4594095</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Arakha M, Pal S, Samantarrai D, Panigrahi TK, Mallick BC, Pramanik K, et al. Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface. Sci Rep. 2015;5:14813.<pub-id pub-id-type="pmid">26437582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep14813</pub-id><pub-id pub-id-type="pmcid">PMC4594095</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Santos</surname><given-names>AC</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Bai</surname><given-names>H</given-names></name><name name-style="western"><surname>Hu</surname><given-names>X</given-names></name><name name-style="western"><surname>Mamidi</surname><given-names>N</given-names></name><etal/></person-group><article-title>Black phosphorous-based biomaterials for bone defect regeneration: a systematic review and meta-analysis</article-title><source>J Nanobiotechnol</source><year>2022</year><volume>20</volume><fpage>522.</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-022-01735-9</pub-id><pub-id pub-id-type="pmcid">PMC9741806</pub-id><pub-id pub-id-type="pmid">36496422</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Huang J, Santos AC, Tan Q, Bai H, Hu X, Mamidi N, et al. Black phosphorous-based biomaterials for bone defect regeneration: a systematic review and meta-analysis. J Nanobiotechnol 2022;20:522.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-022-01735-9</pub-id><pub-id pub-id-type="pmcid">PMC9741806</pub-id><pub-id pub-id-type="pmid">36496422</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Weng</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name><name name-style="western"><surname>Bian</surname><given-names>Y</given-names></name></person-group><article-title>Cemented versus uncemented hemiarthroplasty for femoral neck fractures in elderly patients: a meta-analysis</article-title><source>PLOS ONE</source><year>2013</year><volume>8</volume><fpage>68903.</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0068903</pub-id><pub-id pub-id-type="pmcid">PMC3720851</pub-id><pub-id pub-id-type="pmid">23935902</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Li T, Zhuang Q, Weng X, Zhou L, Bian Y. Cemented versus uncemented hemiarthroplasty for femoral neck fractures in elderly patients: a meta-analysis. PLOS ONE. 2013;8:68903.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0068903</pub-id><pub-id pub-id-type="pmcid">PMC3720851</pub-id><pub-id pub-id-type="pmid">23935902</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bretschneider</surname><given-names>H</given-names></name><name name-style="western"><surname>Quade</surname><given-names>M</given-names></name><name name-style="western"><surname>Lode</surname><given-names>A</given-names></name><name name-style="western"><surname>Gelinsky</surname><given-names>M</given-names></name><name name-style="western"><surname>Rammelt</surname><given-names>S</given-names></name><name name-style="western"><surname>Vater</surname><given-names>C</given-names></name></person-group><article-title>Chemotactic and Angiogenic Potential of Mineralized Collagen Scaffolds Functionalized with Naturally Occurring Bioactive Factor Mixtures to Stimulate Bone Regeneration</article-title><source>Int J Mol Sci</source><year>2021</year><volume>22</volume><fpage>5836.</fpage><pub-id pub-id-type="pmid">34072505</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22115836</pub-id><pub-id pub-id-type="pmcid">PMC8199046</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Bretschneider H, Quade M, Lode A, Gelinsky M, Rammelt S, Vater C. Chemotactic and Angiogenic Potential of Mineralized Collagen Scaffolds Functionalized with Naturally Occurring Bioactive Factor Mixtures to Stimulate Bone Regeneration. Int J Mol Sci. 2021;22:5836.<pub-id pub-id-type="pmid">34072505</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22115836</pub-id><pub-id pub-id-type="pmcid">PMC8199046</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xing</surname><given-names>F</given-names></name><name name-style="western"><surname>Chi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Cui</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Chitin-hydroxyapatite-collagen composite scaffolds for bone regeneration</article-title><source>Int J Biol Macromol</source><year>2021</year><volume>184</volume><fpage>170</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">34052273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijbiomac.2021.05.019</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Xing F, Chi Z, Yang R, Xu D, Cui J, Huang Y, et al. Chitin-hydroxyapatite-collagen composite scaffolds for bone regeneration. Int J Biol Macromol 2021;184:170&#8211;80.<pub-id pub-id-type="pmid">34052273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijbiomac.2021.05.019</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S</given-names></name><name name-style="western"><surname>L&#252;</surname><given-names>Y</given-names></name></person-group><article-title>Efficacy of concentrated growth factors combined with mineralized collagen on quality of life and bone reconstruction of guided bone regeneration</article-title><source>Regen Biomater</source><year>2020</year><volume>7</volume><fpage>313</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">32818060</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rb/rbaa007</pub-id><pub-id pub-id-type="pmcid">PMC7425787</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Dai Y, Han X, Hu L, Wu H, Huang S, L&#252; Y. Efficacy of concentrated growth factors combined with mineralized collagen on quality of life and bone reconstruction of guided bone regeneration. Regen Biomater. 2020;7:313&#8211;20.<pub-id pub-id-type="pmid">32818060</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rb/rbaa007</pub-id><pub-id pub-id-type="pmcid">PMC7425787</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>